Totally Minimized Extracorporeal Circulation: An Important Benefit for Coronary Artery Bypass Grafting in Jehovah's Witnesses
DOI:
https://doi.org/10.1532/hsf.557Abstract
Background: Jehovah's Witnesses who require cardiac surgery represent a challenge to the physician because of their refusal to accept blood transfusions. Because coronary artery bypass grafting (CABG) is performed by most surgeons under cardiopulmonary bypass (CPB), which has potentially deleterious effects on hemostasis, we used a new concept called minimal extracorporeal circulation (MECC). MECC includes heparin-coated tubing, a centrifugal pump, and an oxygenator. There is no venous reservoir or vent, and suction is used through the cell saver. We assessed the hypothesis that MECC in combination with low-volume blood cardioplegia preserves more hemoglobin than conventional CPB in standard CABG.
Methods: In 40 patients of the Jehovah's Witnesses faith undergoing CABG with the use of MECC and intermittent warm blood cardioplegia, clinical and biological data as well as values for parameters of hemolysis (plasma hemoglobin) and myocardial damage (troponin T) were determined. The results were compared with those of a control group of 40 patients who underwent operations with standard CPB.
Results: Demographics, hemodynamics, the number of anastomoses, and CPB and cross-clamp times were comparable between the groups. MECC patients demonstrated significantly lower peak levels of plasma hemoglobin (21.8 ± 114 mg/dL versus 35.4 ± 15 mg/dL) and troponin T (0.12 ± 0.4 ng/mL versus 0.65 ± 0.7 ng/mL), a higher minimum hematocrit level during CPB (30% ± 7% versus 23% ± 6%), and a higher hemoglobin level 2 days after surgery (13 ± 3 g/100 mL versus 9.4 ± 0.98 g/100 mL). Preoperative values were not significantly different.
Conclusion: The use of MECC instead of conventional CPB reduces hemolysis, hemodilution, blood loss, and myocardial damage.
References
Folliguet TA, Philippe F, Larrazet F, et al. 2003. Beating heart revascularization with minimal extracorporeal circulation in patients with a poor ejection fraction. Heart Surg Forum 6:19-23.nForest RJ, Groom RC, Quinn R, Donnelly J, Clark C. 2002. Repair of hypoplastic left heart syndrome of a 4.25-kg Jehovah's Witness. Perfusion 17:221-5.nFromes Y, Gaillard D, Ponzio O, et al. 2002. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 22:527-33.nHelm RE, Rosengart TK, Gomez M, et al. 1998. Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg 65:125-36.nJovanovic S, Hansbro SD, Munsch CM, Cross MH. 2000. Redo cardiac surgery in a Jehovah's Witness: the importance of a multidisciplinary approach to blood conservation. Perfusion 15:251-5.nLiebold A, Reisinger S, Lehle K, Rupprecht L, Philipp A, Birnbaum DE. 2002. Reduced invasiveness of perfusion with a minimized extracorporeal circuit. Thorac Cardiovasc Surg 11:120-2.nMcMullan DM, Beyer EA, Gregoric I, Radovancevic B, Frazier OH. 2000. Left ventricular reduction in a Jehovah's Witness. Ann Thorac Surg 70:958-60; discussion 960-1.nDavit S, Senkaya I, Ercan AK, Kan II, Ozkan H. 2002. Is 100% beating heart coronary by-pass justified? Cardiovasc Surg 10:579-85.nEngoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. 2002. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 74:1180-6.nOtt DA, Cooley DA. 1977. Cardiovascular surgery in Jehovah's Witnesses: report of 542 operations without blood transfusion. JAMA 238:1256-8.nSpiess BD. 2002. Transfusion and outcome in heart surgery [editorial]. Ann Thorac Surg 74:986-7.nBrest van Kempen AB, Gasiorek JM, Bloemendaal K, Storm van Leeuwen RP, Bulder ER. 2002. Low-prime perfusion circuit and autologous priming in CABG surgery on a Jehovah's Witness: a case report. Perfusion 17:69-72.nBurnett CM, Duncan JM, Vega JD, Lonquist JL, Sweeney MS, Frazier OH. 1990. Heart transplantation in Jehovah's Witnesses: an initial experience and follow-up. Arch Surg 125:1430-3.n
